DCM Shriram has reported robust financial results for the fiscal year ended March 31, 2026. The company achieved a standalone profit after tax of ₹837.55 crore, marking a significant increase from the previous year. The Board of Directors has recommended a final dividend of 200% (₹4 per share), bringing the total dividend for the year to 560% (₹11.20 per share). Furthermore, the company announced major capital investment plans for its subsidiary, Hindusthan Speciality Chemicals Limited.
Financial Performance Overview
For the financial year ended March 31, 2026, DCM Shriram demonstrated strong operational growth. The company reported a total standalone income of ₹13,995.33 crore, up from ₹12,584.31 crore in the previous fiscal year. Consolidated performance also saw positive momentum, with a profit after tax of ₹855.98 crore. This growth reflects the company’s resilient performance across its diverse business segments, including Chemicals, Vinyl, and Sugar.
Dividend Payout to Shareholders
Reflecting the company’s strong financial health and commitment to shareholder value, the Board has recommended a final dividend of ₹4 per equity share (face value of ₹2). When combined with the two interim dividends of ₹3.60 each declared earlier in the year, the total dividend payout for FY 2025-26 reaches ₹11.20 per share. The final dividend is subject to approval at the upcoming 37th Annual General Meeting scheduled for August 18, 2026.
Strategic Investments in Advanced Materials
The company is doubling down on its growth strategy within the chemicals sector. The Board has approved a capital expenditure plan for its wholly-owned subsidiary, Hindusthan Speciality Chemicals Limited (HSCL). This investment of ₹101 crore is aimed at increasing the Formulated Resins capacity by 36,000 TPA, targeting a total production capacity of 50,000 TPA. To support this, DCM Shriram will provide financial assistance of up to ₹100 crore to HSCL through a mix of equity and debt, underscoring its focus on the high-growth advanced materials portfolio.
Operational Milestones
In addition to financial results, the company successfully commissioned the balance capacity of 17,000 TPA of Epichlorohydrin (ECH) at its Jhagadia chemical complex in Gujarat as of April 1, 2026. This project completion brings the total ECH capacity to 52,000 TPA, further strengthening the company’s leadership in the domestic chemical manufacturing landscape.
Source: BSE
